Author Question: Which of the following statements is true regarding financial resources and interest group success? ... (Read 77 times)

CharlieWard

  • Hero Member
  • *****
  • Posts: 578
Which of the following statements is true regarding financial resources and interest group success?
 
  a. Financial resources have no impact on outcomes or group membership in interest groups.
  b. An interest group without strong financial capability will never achieve its goals.
   c. An interest group with financial resources may benefit indirectly by being able to hire better lobbyists.
   d. Financial capability is the key factor in advocacy success.

Question 2

Which of the following is not a resource that interest groups draw on?
 
  a. Membership size
  b. Presidential endorsement
  c. Economic strength
  d. Relationship with the media



brittiany.barnes

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

c

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library